$CATX
Perspective Therapeutics, Inc.
XASE•Health Care•Pharmaceutical Preparations
Perspective Therapeutics, Inc.
XASE•Health Care•Pharmaceutical Preparations
Why is CATX down today? It is at $0.754 (-3.85%), and our scanner flagged it 167 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CATX spikes, and full due diligence on CATX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CATX 167 times in the last 30 days. Create a free account to track $CATX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how CATX traded in the last session, Friday (last price and move above). Our scanner fired 12 unusual-volume and momentum alerts on CATX on Friday, peaking at 9.9x its normal volume.
Likely catalystPerspective Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 19, 2026 · 3 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Williamson Robert F Iii Director | Bought (open market) | +15K 0.01% of company | added 28% | 68K | $12K at $0.800 | Nov 18, 26 |
Williamson Robert F Iii Director | Bought (open market) | +25K 0.02% of company | added 88% | 53K | $21K at $0.840 | Nov 17, 26 |
Morich Frank Director | Bought (open market) | +15K 0.01% of company | added 100% | 30K | $14K at $0.940 | Nov 16, 26 |
Puhlmann Markus Officer | Bought (open market) | +35K 0.03% of company | added 24% | 179K | $29K at $0.840 | Nov 12, 26 |
Woods Lori A Director | Bought (open market) | +24K 0.02% of company | added 100% | 29K | $20K at $0.840 | Nov 12, 26 |
Morich Frank Director | Bought (open market) | +15K 0.01% of company | n/a | 15K | $15K at $1.00 | Nov 12, 26 |
Williamson Robert F Iii Director | Bought (open market) | +19K 0.02% of company | added 100% | 28K | $16K at $0.840 | Nov 12, 26 |
Williamson Robert F Iii Director | Bought (open market) | +6K | added 5.8% | 115K | $5K at $0.840 | Nov 12, 26 |
Spoor Johan M. Officer | Bought (open market) | +47K 0.04% of company | added 79% | 106K | $38K at $0.810 | Nov 11, 26 |
Puhlmann Markus Officer | Bought (open market) | +6K | added 4.4% | 144K | $5K at $0.830 | Nov 11, 26 |
Lantheus Alpha Therapy, Llc Beneficial Owner (10%) | Sold (automatic/other) | -167K 0.1% of company | sold 1.5% | 11.27M | $527K at $3.15 | Sep 4, 26 |
Lantheus Alpha Therapy, Llc Beneficial Owner (10%) | Sold (automatic/other) | -81K 0.07% of company | sold 0.7% | 11.44M | $251K at $3.11 | Sep 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how CATX traded in the last session, Friday (last price and move above). Our scanner fired 12 unusual-volume and momentum alerts on CATX on Friday, peaking at 9.9x its normal volume.
CATX last traded at $0.754, down 3.85% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CATX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CATX 167 times in the last 30 days.
CATX (Perspective Therapeutics, Inc.) trades on XASE, with a market cap of about $91M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CATX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CATX discussion
Sign in to ask a question or join the discussion.